Caris Life Sciences Inc. (CAI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Caris Life Sciences Inc.

    NASDAQ: CAI · Real-Time Price · USD
    34.06
    -0.15 (-0.44%)
    At close: Sep 12, 2025, 3:59 PM
    33.99
    -0.21%
    After-hours: Sep 12, 2025, 06:53 PM EDT

    Caris Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 412.26M 306.13M 258.49M
    Cost of Revenue
    		 233.48M 216.82M 178.46M
    Gross Profit
    		 178.78M 89.31M 80.02M
    Operating Income
    		 -257.12M -319.55M -315.76M
    Interest Income
    		 7.12M 11.26M 947K
    Pretax Income
    		 -281.89M -341.42M -320.83M
    Net Income
    		 -281.89M -341.42M -320.83M
    Selling & General & Admin
    		 321.86M 291.48M 294.51M
    Research & Development
    		 113.92M 116.88M 101.27M
    Other Expenses
    		 128K 500K n/a
    Operating Expenses
    		 435.9M 408.86M 395.78M
    Interest Expense
    		 50.02M 31.61M 26.68M
    Selling & Marketing Expenses
    		 148.3M 139.53M 138.36M
    Cost & Expenses
    		 669.38M 625.68M 574.24M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 254.66M 254.66M 254.79M
    Shares Outstanding (Diluted)
    		 254.66M 254.66M 254.79M
    EPS (Basic)
    		 -2.7 -1.82 -1.57
    EPS (Diluted)
    		 -2.7 -1.82 -1.57
    EBITDA
    		 -182.95M -260.8M -245.89M
    EBIT
    		 -231.87M -309.81M -294.15M
    Depreciation & Amortization
    		 48.91M 49M 48.25M

    Add to Watchlist